Publications

Export 16 results:
Author Title [ Type(Desc)] Year
Filters: Author is Nakajima, Shinichiro  [Clear All Filters]
Journal Article
Caravaggio F, Fervaha G, Iwata Y, Plitman E, Chung JKu, Nakajima S, Mar W, Gerretsen P, Kim J, M Chakravarty M et al..  2018.  Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia.. Int J Geriatr Psychiatry. 33(3):523-530.
Chung JKu, Nakajima S, Shinagawa S, Plitman E, M Chakravarty M, Iwata Y, Caravaggio F, Pollock BG, Gerretsen P, Graff-Guerrero A.  2016.  Benzodiazepine Use Attenuates Cortical β-Amyloid and is Not Associated with Progressive Cognitive Decline in Nondemented Elderly Adults: A Pilot Study Using F(18)-Florbetapir Positron Emission Tomography.. Am J Geriatr Psychiatry. 24(11):1028-1039.
Chung JKu, Plitman E, Nakajima S, M Chakravarty M, Caravaggio F, Gerretsen P, Iwata Y, Graff-Guerrero A.  2016.  Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.. J Geriatr Psychiatry Neurol. 29(3):149-59.
Chung JKu, Plitman E, Nakajima S, M Chakravarty M, Caravaggio F, Takeuchi H, Gerretsen P, Iwata Y, Patel R, Mulsant BH et al..  2016.  Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment.. J Alzheimers Dis. 49(3):743-54.
Chung JKu, Plitman E, Nakajima S, Caravaggio F, Shinagawa S, Iwata Y, Gerretsen P, Kim J, Takeuchi H, Patel R et al..  2017.  The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report.. J Alzheimers Dis. 60(2):341-347.
Plitman E, Nakajima S, de la Fuente-Sandoval C, Gerretsen P, M Chakravarty M, Kobylianskii J, Chung JKu, Caravaggio F, Iwata Y, Remington G et al..  2014.  Glutamate-mediated excitotoxicity in schizophrenia: a review.. Eur Neuropsychopharmacol. 24(10):1591-605.
Chung JKu, Plitman E, Nakajima S, Caravaggio F, Iwata Y, Gerretsen P, Kim J, Takeuchi H, Shinagawa S, Patel R et al..  2017.  Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.. J Alzheimers Dis. 58(3):747-762.
Caravaggio F, Gerretsen P, Mar W, Chung JKu, Plitman E, Nakajima S, Kim J, Iwata Y, Patel R, M Chakravarty M et al..  2017.  Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning.. Psychoneuroendocrinology. 81:80-87.
Plitman E, Iwata Y, Caravaggio F, Nakajima S, Chung JKu, Gerretsen P, Kim J, Takeuchi H, M Chakravarty M, Remington G et al..  2017.  Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.. Schizophr Bull.
Tarumi R, Tsugawa S, Noda Y, Plitman E, Honda S, Matsushita K, Chavez S, Sawada K, Wada M, Matsui M et al..  2019.  Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.. Neuropsychopharmacology.
Chung JKu, Plitman E, Nakajima S, Chow TW, M Chakravarty M, Caravaggio F, Gerretsen P, Brown EE, Iwata Y, Mulsant BH et al..  2015.  Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment.. J Alzheimers Dis. 45(3):907-19.
Chung JKu, Plitman E, Nakajima S, Chow TW, M Chakravarty M, Caravaggio F, Gerretsen P, Brown EE, Iwata Y, Mulsant BH et al..  2016.  Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment.. J Alzheimers Dis. 49(4):1189-90.
Kim J, Plitman E, Iwata Y, Nakajima S, Mar W, Patel R, Chavez S, Chung JKu, Caravaggio F, M Chakravarty M et al..  2019.  Neuroanatomical profiles of treatment-resistance in patients with schizophrenia spectrum disorders.. Prog Neuropsychopharmacol Biol Psychiatry. :109839.
Wada M, Kurose S, Miyazaki T, Nakajima S, Masuda F, Mimura Y, Nishida H, Ogyu K, Tsugawa S, Mashima Y et al..  2019.  The P300 event-related potential in bipolar disorder: A systematic review and meta-analysis.. J Affect Disord. 256:234-249.
Plitman E, Chavez S, Nakajima S, Iwata Y, Chung JKu, Caravaggio F, Kim J, Alshehri Y, M Chakravarty M, De Luca V et al..  2018.  Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.. Psychiatry Res Neuroimaging. 273:16-24.
Chung JKu, Nakajima S, Plitman E, Iwata Y, Uy D, Gerretsen P, Caravaggio F, M Chakravarty M, Graff-Guerrero A.  2016.  Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review.. Am J Geriatr Psychiatry. 24(10):923-39.